Ginkgolide C (Li et al., 2023) reduces inflammation-induced injury caused by cerebral ischemia/reperfusion by inhibiting the CD40/NF-κB pathway, improves microvascular ultrastructural characteristics, and ameliorates BBB disruption, thereby reducing cerebral edema. The gene discussed is NFKB1; the disease is brain ischemia.